The Biologics & Biosimilars Collective Intelligence Consortium (BBCIC) announced that it has received a major grant from the Food & Drug Administration (FDA) in support of biosimilars research. The award provides $1.3 million over two years for a new BBCIC study focused on increasing the efficiency of biosimilar drug development and review.
G-CSF Scoping Review Poster presented:
Variation in evaluations of granulocyte colony stimulating factor use: a scoping review of observational studies.
Resources that support BBCIC’s effort to engage data consortium, managed care specialty drug experts, researchers, and industry to monitor biosimilars.
